Defitleilty good news. So where is the PR from PGNX telling us about approval and the milestone payment that comes with it. I mean approval isn't a shock to PGNX so they should have been ready.
Looks like you got your wish ca_fisherman. Congratulations on booking some profits!! I am impressed by how PGNX has blown by $7. I am holding on tight and hoping for more.
You know it. My biggest holdings are MNTA, ENTA, MDVN, SGEN and PGNX, so you know I am happy! I bought SGEN several times when it was in the mid $30s recently but wish I had bought more. On the negative side, I sold off most of my IMGN when the so missed the big pop when their conjugated antibody IMGN853 gave stellar results in a phase I trial for Ovarian cancer. That really caught me by surprise, but I think I will start buying soon.
ostermanlarry, you are a certified moron. The efficacy of Ganetespib is unclear at this time. However, what is crystal clear is that it has an excellent safety profile, much safer than most anti-cancer drugs.
Now that's what I am talking about. PGNX should be over $8 soon, and even that isn't the ceiling. Come on and get the Oral Relistor formulation submitted and get a European partner for Relistor!!
This new Relistor application is for a formulation change of an approved product. Obviously the FDA must review all the clinical data, but the approval is almost a foregone conclusion based on the data that PGNX/SLXP has shown.
syenfrout, I sold some more SNTA yesterday to reduce my holdings to 40% of what they were earlier this year. SNTA is being passed by in NSCLC. I am dubious of its prospects there. The wild-card that might help SNTA is the I-Spy Breast cancer trials.I think once they get the HSP90i-conjugates going in trials, they will become more attractive, but that won't start until early 2016.
What falling knife are you talking about? It sure as hell isn't MNTA.
pgp, I doubt there is any factual data driving the stock swings. The momentum traders get hold of a lightly trader stock and the wild gyrations begin. The options are to sell some when the price spikes high unexpectedly and without news, buy some when it drops low unexpectedly and without news, or sit tight and watch with amazement. I must admit I came close to selling some over $8 but held off.